The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
about
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancerDeath receptor-ligand systems in cancer, cell death, and inflammationIn chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areasExpression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosisTransforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cellsApoptotic regulation of epithelial cellular extrusionHyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells.Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis.Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Gene transcription profile of the detached retina (An AOS Thesis).Expression of the Fas-ligand gene in ejaculated sperm from adolescents with and without varicocele.Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.Human and mouse granzyme M display divergent and species-specific substrate specificities.Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathwayCD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions.Role of RANK ligand in mediating increased bone resorption in early postmenopausal womenAlpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cellsMolecular mechanisms of sulfasalazine-induced T-cell apoptosisTargeting cell death in tumors by activating caspases.Antitumor mechanisms of amino Acid hydroxyurea derivatives in the metastatic colon cancer model.Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.Death receptors in chemotherapy and cancer.Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylationTumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytesSuramin: potential in acute liver failure.Selective activation of TNFR1 and NF-κB inhibition by a novel biyouyanagin analogue promotes apoptosis in acute leukemia cells.Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells.MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.Neural precursor cells and their role in neuro-oncology.CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice
P2860
Q24305298-F631DCE8-176F-45E5-B39C-E999B6E730B4Q24801183-4B0F7BFE-D204-4B05-AE43-A84A813D193CQ26865568-A4614768-1008-4807-9B52-51951FE918A0Q28179380-F8BF5BA9-4E3B-45CB-A54A-FC1982B6E2A5Q28363205-2FAADE0F-1155-4537-AC64-DBC4D12DD293Q28580989-DC282B95-CF77-49D1-8241-98FCA2FB3B82Q30638314-1F21D8A6-C992-4B4A-BFAE-86F46D767A52Q33222947-2819E871-4B94-4155-87DD-781E63FA5BF2Q33495179-2833DB15-607E-40A2-887C-BBA2980A3F2DQ33569854-37F83731-2156-4816-AE09-22B9A3CBF27AQ33578562-52BF73F9-152B-4FB4-8D84-FBBCC09AB219Q33614335-D8F2B4D5-4A39-4BF8-A5CE-0B0FA0515B0DQ33623534-56BEE451-A429-4C55-BC02-D2A958BA39DAQ33743554-95D7E546-F6B8-4356-AE72-E25C20966E68Q33844897-14C66698-500A-4A90-9ACF-495BAD5ACA27Q33896439-C9DBC6B2-DC9C-43A7-AE91-F8212CD659BEQ34139182-0222D88B-1054-4EC9-9E1C-B3ACC3971F08Q34266288-93AF4E21-6C39-4D82-BD20-9417B8F0FCC5Q34266298-763FE9D7-497D-4523-93B4-A24E1BF49363Q34301824-FAC44597-94C1-488F-A7E2-3CA02F98736FQ34482821-A3AD1454-B6B4-4D6E-B47D-EE2051C31F5CQ34492106-57BE6B0F-53AA-4988-9F90-349ADF357A4AQ34912769-B0E82ED0-2A0B-4A93-A837-01BCE1B1D75EQ35010607-B5554A51-8A20-4051-942A-35B9298CD1CBQ35044669-5214DDA2-BAF3-43C7-9B03-A3AEFFEF7FA9Q35058822-FCE625E5-EF60-4B5D-91F8-39C6C88BFF13Q35058878-7FD09A3C-5289-4852-AA79-4AF8EF11019FQ35073199-00B1017C-D6C5-4E7C-B7FE-BA1A4AEC1226Q35743149-B3C4E56D-4A3B-46E8-8226-801E7C2ADAD3Q35828472-0BBFF435-BCD8-4570-AFE8-347D9AAC70A9Q35836872-780151D0-DF92-433D-BD6F-4256EDD11BFAQ35842625-54C73AEF-57E3-4BAE-ADD0-29690906EE00Q35866576-46C79363-EB48-464B-A735-59805A99176FQ35906994-FF082CA9-037A-4B46-BF98-CA28E287BEE2Q35995213-547C8AAB-790B-4427-87FA-4CFC6E43F15BQ36001340-245CB65A-10D3-466C-AAD0-B8E85CA482D5Q36008004-C22641BA-BAA9-4BEC-AB9C-70D15E2FE3E8Q36041152-C18D1B83-A382-4A2D-B97A-0111E56B4E8AQ36041769-18A7DCD8-F45D-4068-B906-A5352F68B784Q36085110-646E35E6-5E7E-41BC-9A1F-BCE6CE33DC6A
P2860
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@ast
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@en
type
label
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@ast
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@en
prefLabel
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@ast
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@en
P356
P1476
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
@en
P2093
P356
10.1006/EXCR.2000.4840
P407
P577
2000-04-01T00:00:00Z